Basic Information
| LncRNA/CircRNA Name | ncHDAC5 |
| Synonyms | HDAC5, HD5, NY-CO-9 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | renal cell carcinoma |
| ICD-0-3 | C64.9 |
| Methods | Microarray, qPCR, Western blot etc. |
| Sample | RCC tissues |
| Expression Pattern | up-regulated |
| Function Description | Four lncRNAs mapping to intronic regions, namely ncC11orf49, ncHDAC5, ncRAB31 and ncSRPK1, showed a significant differential expression between tumor and nontumor paired samples as measured by qPCR. |
| Pubmed ID | 24238219 |
| Year | 2013 |
| Title | Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations. |
External Links
| Links for ncHDAC5 | GenBank HGNC NONCODE |
| Links for renal cell carcinoma | OMIM COSMIC |